Drugs / aQII-9 Investigational
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04782323 | Apr → Sep 2021 | influenza | Seqirus | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | aQII-9 Investigational | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04782323 ↗ |
| Modality | Vaccine | “Investigational aQII-9 Investigational MF59 Adjuvanted Quadrivalent Influenza vaccine” NCT04782323 ↗ |